Gullans Steven R. Ph.D. Insider Trades

Insider Trading History

Track insider trading activity for Gullans Steven R. Ph.D.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
iSpecimen
iSpecimen ISPC
Director
Holding Value $107k 33,525 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 10,000 shares
$10.50
$3.18
iSpecimen
iSpecimen ISPC
Director
Holding Value $74.8k 23,525 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 10,000 shares
$28.20
$3.18
iSpecimen
iSpecimen ISPC
Director
Holding Value $10.3k 3,250 shares
Last Trade
Jan 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.44k 125 shares
$27.50
$3.18
iSpecimen
iSpecimen ISPC
Director
Holding Value $43k 13,525 shares
Last Trade
Jul 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.7M 13,525 shares
$125.60
$3.18
iSpecimen
iSpecimen ISPC
Director
Holding Value $0 0 shares
Last Trade
Jun 16, 2021 Sale
No data
No data
$3.18
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $142k 60,000 shares
Last Trade
Jan 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121M 60,000 shares
$2,013.60
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
President & CEO
Holding Value $708k 300,000 shares
Last Trade
Jul 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.4M 300,000 shares
$18.00
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
President & CEO
Holding Value $118k 50,000 shares
Last Trade
May 22, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.54M 50,000 shares
$150.75
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
President & CEO
Holding Value $354k 150,000 shares
Last Trade
May 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.9M 150,000 shares
$139.00
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Interim President & CEO
Holding Value $2.2M 930,252 shares
Last Trade
Feb 08, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.1M 71,429 shares
$156.00
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Interim President & CEO
Holding Value $142k 60,000 shares
Last Trade
Jan 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7M 60,000 shares
$261.00
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Interim President & CEO
Holding Value $142k 60,000 shares
Last Trade
May 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.4M 60,000 shares
$256.50
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $2.03M 858,823 shares
Last Trade
Mar 10, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.2M 92,397 shares
$229.25
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $722k 306,025 shares
Last Trade
Aug 10, 2016 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$71.5M 306,025 shares
$233.50
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $1.9M 806,025 shares
Last Trade
Aug 10, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$117M 500,000 shares
$233.50
$2.36
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $142k 60,000 shares
Last Trade
Aug 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.36

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up